Disclosure Index: B
Disclosure Index: B
Oxford outcomes:
Consulting fees
Otsuka: Consulting fees
Hexal Pharma: Consulting fees
PCM scientific: Consulting fees
Viforpharma: Consulting fees and Research grants
Medice: Consulting fees
Lilly: Consulting fees and Speakers' bureau
Shire: Consulting fees , Research grants and Speakers' bureau
Novartis: Consulting fees
Otsuka: Consulting fees
Hexal Pharma: Consulting fees
PCM scientific: Consulting fees
Viforpharma: Consulting fees and Research grants
Medice: Consulting fees
Lilly: Consulting fees and Speakers' bureau
Shire: Consulting fees , Research grants and Speakers' bureau
Novartis: Consulting fees
Roche Product Development:
Employment (full or part-time)
and
Stock
M-CHAT, LLC:
Ownership or partnership
and
Receipt of royalties
Autism Ontario:
Consulting fees
Seaside Therapeutics:
Research grants
Roche: Consulting fees and Research grants
Novartis: Consulting fees and Research grants
Neuren Pharmaceuticals: Research grants
Alcobra Pharma: Research grants
Asuragen: Research grants
Roche: Consulting fees and Research grants
Novartis: Consulting fees and Research grants
Neuren Pharmaceuticals: Research grants
Alcobra Pharma: Research grants
Asuragen: Research grants
F. Hoffmann-La Roche :
Employment (full or part-time)
BioMarin Pharmaceuticals:
Consulting fees
F. Hoffmann La Roche :
Employment (full or part-time)
F. Hoffmann-La Roche Ltd:
Employment (full or part-time)
Society for Treatment of Autism:
Employment (full or part-time)
PEERS Play:
Consulting fees
and
Ownership or partnership
Janssen:
Consulting fees
Eli Lilly: Consulting fees
Lundbeck: Consulting fees
Roche: Consulting fees
Servier: Consulting fees
Cilag BV: Consulting fees
Eli Lilly: Consulting fees
Lundbeck: Consulting fees
Roche: Consulting fees
Servier: Consulting fees
Cilag BV: Consulting fees
Lilly:
Consulting fees
,
Research grants
and
Speakers' bureau
Janssen: Consulting fees , Research grants and Speakers' bureau
Roche: collaborating in IMI grant
Lundbeck: Consulting fees
Servier: Consulting fees
Janssen: Consulting fees , Research grants and Speakers' bureau
Roche: collaborating in IMI grant
Lundbeck: Consulting fees
Servier: Consulting fees
Stemina Biomarker Discovery:
Employment (full or part-time)
Mount Sinai and JDB:
hold a patent for IGF-1 in the treatment of PMS
Otsuka Pharm:
Consulting fees
Xoma: Consulting fees
Xoma: Consulting fees